跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SIILTIBCY (0,5 MICROGRAMOS + 0,5 MICROGRAMOS)/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SIILTIBCY (0,5 MICROGRAMOS + 0,5 MICROGRAMOS)/ML SOLUCION INYECTABLE
Approved
STANDARD
SIILTIBCY (0,5 MICROGRAMOS + 0,5 MICROGRAMOS)/ML SOLUCION INYECTABLE
Serum Life Science Europe Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 21, 2025
Approval ID
7a12e7906a606110
Company
Serum Life Science Europe Gmbh
Type
Standard
Approval Details
Approval Id
7a12e7906a606110
Drug Cima Aemps Name
SIILTIBCY (0,5 MICROGRAMOS + 0,5 MICROGRAMOS)/ML SOLUCION INYECTABLE
Register Number
1241882001
Holder Company Name
Serum Life Science Europe Gmbh
Marketing Company Name
2pirpharma S.L.
Holder Company Detail Path
/organization/serum-life-science-europe-gmbh
Authorization Date
2025-07-21
Dosage Form
SOLUCIÓN INYECTABLE
Dose
(0,5 microgramos + 0,5 microgramos) / mL
Route Of Administration
VÍA INTRADÉRMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Serum Life Science Europe Gmbh
Company Detail Path
/organization/serum-life-science-europe-gmbh
Company Information
Pharmaceutical Company Name
Serum Life Science Europe GmbH
Country Name
Germany
City Name
hannover,niedersachsen,country_de
Address
Ahrensburger Str. 1
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 21, 2025
Approval ID
7a12e7906a606110
Type
Standard
Back to CIMA-AEMPS Approvals